WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
SHANGHAI and LEVERKUSEN – WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Bayer jointly announced an acquisition agreement that WuXi Biologics Germany GmbH will take over the operations of one of Bayer’s final drug product manufacturing plants in Leverkusen, Germany, and purchase the associated equipment, in combination with a long-term lease contract for the building.
Based on a manufacturing agreement to be negotiated, the plant would be operated by WuXi Biologics and serve as a back-up site for the final product manufacturing of Kovaltry™, an antihemophilic factor (recombinant). The transaction is expected to be concluded in the coming months subject to the satisfaction of customary closing conditions. Financial details were not disclosed.
“We are excited to sign this acquisition agreement with Bayer, allowing us to have quick access to high quality drug product manufacturing capacities and capabilities,” said Dr. Chris Chen, CEO of WuXi Biologics. “Our business in EU, US and China market has experienced robust growth in the past few years. This additional drug product plant further confirms our commitment to ‘Global Dual Sourcing within WuXi Biologics’ strategy. WuXi Biologics will continue to expand our worldwide capacity, providing global partners with a robust and premier-quality supply chain network to benefit patients worldwide.”
Latest news
TotalEnergies’ Antwerp Platform Adapts to Energy Transition Challenges and Market Trends
Port Of Antwerp →By adapting and investing regularly in our Antwerp site, we’re securing its long-term future and ensuring that this integrated refining and petrochemicals platform remains TotalEnergies’ most effic...
Solvay advances European rare earths production through capacity expansion
The inauguration of Solvay’s new production line in France marks the start of rare earth production for permanent magnets, enhancing Europe's sovereignty and supporting the Critical Raw Materials A...
Clariant's MegaMax™ 900 catalyst: Powerful start at European Energy's e-methanol plant
European Energy successfully started up their e-methanol plant in Kasso, Denmark, using Clariant’s MegaMax 900 catalyst. The Power-to-X plant is one of the world’s first and currently largest comme...
Kazakhstan’s largest petrochemical project: first piles driven for polyethylene plant in Atyrau
The construction of the plant, which has a capacity of 1.25 million tons of polyethylene per year and an investment of approximately 7 billion US dollars, is expected to be completed by 2028, with ...